Evidence map›Paper›PMID 22679098›Full record

ArticleScience (New York, N.Y.)2012

Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface.

Patrice Nancy, Elisa Tagliani, Chin-Siean Tay, Patrik Asp, David E Levy, Adrian Erlebacher

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 234 papers.

0numbers the graph read from it
0cells of the map it votes in
234citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

234 citing papers in PubMed, 417 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  7. Article
  8. Reversing pregnancy-induced B cell sensitization to facilitate the induction of transplant tolerance in postpartum recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Chemokines in Pregnancy.Biomolecules · 2025
    Review
  20. Role of CD138Biomedicines · 2025
    Review

174 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Patrice NancyDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Elisa Tagliani
Chin-Siean Tay
Patrik Asp
David E Levy
Adrian Erlebacher
New York University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Dendritic cell behavior at the maternal/fetal interfaceR01AI062980 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ERLEBACHER, ADRIAN · 2005 to 2009
$1.9M
NCI NIH HHS P30 CA016087NCI NIH HHS P30CA016087NIAID NIH HHS R01 AI062980NIAID NIH HHS R01AI062980
6 · The paper itself

Abstract

The chemokine-mediated recruitment of effector T cells to sites of inflammation is a central feature of the immune response. The extent to which chemokine expression levels are limited by the intrinsic developmental characteristics of a tissue has remained unexplored. We show in mice that effector T cells cannot accumulate within the decidua, the specialized stromal tissue encapsulating the fetus and placenta. Impaired accumulation was in part attributable to the epigenetic silencing of key T cell-attracting inflammatory chemokine genes in decidual stromal cells, as evidenced by promoter accrual of repressive histone marks. These findings give insight into mechanisms of fetomaternal immune tolerance, as well as reveal the epigenetic modification of tissue stromal cells as a modality for limiting effector T cell trafficking.

Indexed as

Gene SilencingImmune ToleranceAnimalsChemokine CCL5Chemokine CXCL10Chemokine CXCL11Chemokine CXCL9ChemokinesChromatin ImmunoprecipitationDeciduaEndometriumFemaleHistonesImmunologic MemoryInflammationMethylationCcl5 protein, mouseChemokine CCL5Chemokine CXCL10Chemokine CXCL11Chemokine CXCL9ChemokinesCxcl10 protein, mouseCxcl9 protein, mouseCxcr3 protein, mouseHistonesOvalbuminReceptors, CXCR3

Identifiers

PMID22679098
PMCPMC3727649
OpenAlexW2137938346

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.